Eyenovia, INC Form 4 insider transactions

Director Happy David Walters acquired 58,917 shares of common stock in Hyperion Defi, Inc. on June 30, 2026.

Ellen R. Strahlman, a Director at Hyperion Defi, Inc., reported a transaction involving 58,917 shares of common stock on June 30, 2026.

Rachel Jacobson, a Director at Hyperion Defi, Inc. (HYPD), acquired 58,917 shares of common stock on June 30, 2026, as part of a restricted stock unit award.

Michael S. Geltzeiler, a Director at Hyperion DeFi, Inc. (HYPD), reported the acquisition of 58,917 shares of common stock.

Hyperion DeFi CEO Hyunsu Jung acquired 8,000 shares of common stock through open market purchases.

CEO Hyunsu Jung disposed of 40,000 shares of Hyperion DeFi, Inc. to satisfy tax obligations related to restricted stock unit vesting.

Hyperion DeFi's Chief Financial Officer, David R. Knox, disposed of 20,831 common shares to cover tax withholding obligations.

Hyperion DeFi's General Counsel, Robert Rubenstein, was granted 75,000 restricted stock units (RSUs) with a vesting schedule tied to continued employment.

Hyperion DeFi's Chief Financial Officer, David R. Knox, increased his stake in the company by purchasing 27,950 shares of common stock.

Hyperion DeFi Director Ellen R. Strahlman increased her beneficial ownership of common stock through open market purchases in late December 2025, signaling confidence in the company.

Hyperion DeFi's Interim CEO and Chief Investment Officer, Hyunsu Jung, reported the withholding of 82,324 common shares to cover tax obligations related to restricted stock unit vesting.

Hyperion DeFi Director Ellen R. Strahlman and her spouse acquired a combined 38,444 shares of common stock in open market purchases.

Happy David Walters, a director at Hyperion DeFi, Inc., acquired 61,930 shares of common stock, signaling increased insider confidence.

Hyperion DeFi Director Michael S. Geltzeiler purchased 30,000 shares of common stock at an average price of $3.007 per share.

Hyperion DeFi's Chief Financial Officer, David R. Knox, was granted 300,000 Restricted Stock Units, with vesting tied to time and market capitalization milestones.

Hyperion DeFi Director Happy David Walters received 50,000 restricted stock units as compensation, vesting through November 2026.

Hyperion DeFi, Inc. has filed a Form 4 reporting a future grant of 1,000,000 performance-based shares to its Chief Investment Officer, Hyunsu Jung, with vesting tied to significant market capitalization milestones.

Hyperion Defi, Inc. Director Rachel Jacobson was granted 50,000 restricted stock units, vesting through August 2026.

Hyperion DeFi Director Ellen R. Strahlman was granted 50,000 restricted stock units, vesting through August 2026, increasing her direct beneficial ownership to 56,706 shares.

Hyperion DeFi, Inc. Director Michael S. Geltzeiler was granted 50,000 restricted stock units, vesting through August 2026.

Hyperion DeFi, Inc. has reported the grant of 500,000 shares of common stock to Hyunsu Jung, effective with his start date as Chief Investment Officer and Director.

Hyperion DeFi, Inc. Director Rachel Jacobson acquired 5,000 shares of common stock on June 13, 2025, which vested upon the closing of a private placement financing on June 20, 2025.

Hyperion DeFi, Inc. CEO and Director Michael M. Rowe reported the acquisition of 6,600 shares of common stock, which vested in full upon the closing of the company's private placement financing on June 20, 2025.

Hyperion DeFi, Inc. Director Michael S. Geltzeiler acquired 7,000 shares of common stock at a price of $0, with the grant vesting upon the closing of the company's private placement financing on June 20, 2025.

Hyperion DeFi, Inc. Director Ellen R. Strahlman acquired 5,000 shares of common stock through a grant that vested upon the closing of a private placement financing.

Avenue Capital Management II, L.P. and its affiliated funds have amended their loan agreement with Eyenovia, Inc., allowing conversion of up to $10 million in debt into common stock at $1.68 per share, subject to a 9.99% beneficial ownership cap.

Ellen Strahlman, a director at Eyenovia, Inc., files an amended Form 4 to correct a clerical error in a previous filing regarding her securities ownership, following a reverse stock split and ahead of a proposed merger with Betaliq, Inc.

Ram Palanki, a director at Eyenovia, Inc., files an amended Form 4 to correct a clerical error in the original filing regarding the amount of securities beneficially owned, following a reverse stock split and in anticipation of a business combination with Betaliq, Inc.

Charles E. Mather IV, a director at Eyenovia, Inc., files an amended Form 4/A to correct a clerical error in a previous filing regarding his securities ownership, following a reverse stock split and in anticipation of a business combination with Betaliq, Inc.

Rachel Jacobson, a director at Eyenovia, Inc., files an amended Form 4/A to correct a clerical error in the original filing regarding the amount of securities beneficially owned, following a reverse stock split and ahead of a proposed business combination with Betaliq, Inc.